3M completes acquisition of Arizant

21 Oct 2010

3M has completed its acquisition of Arizant Inc., a manufacturer of patient warming solutions designed to prevent hypothermia in surgical settings.

Patient warming is a highly strategic adjacency for 3M and integral to infection prevention. Arizant expands 3M’s infection prevention offerings and will help to drive growth internationally.

Arizant, headquartered in Eden Prairie, Minnesota, and with offices in France, Germany, Belgium, Austria and the UK, was majority-owned by private equity firm Court Square Capital since 2004,

It created the category of forced-air patient warming with the introduction of Bair Hugger therapy in 1987. Today, Arizant products help maintain normal body temperature, known as normothermia, in more than 20 million surgical patients annually as part of an effort to help prevent surgical site infections and other serious complications associated with surgical hypothermia.

3M’s infection prevention business helps hospitals reduce healthcare-associated infections. Its wide variety of products and systems for controlling the risk of infection includes applications for sterilization and monitoring, hand hygiene, perioperative preps, and surgical drapes.


To top